Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Trading Up 651.0 %

NYSE AMPE opened at $0.08 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $7.47. The firm has a market cap of $85,614.00, a P/E ratio of -0.01 and a beta of 3.73.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.